title: [Effects of chronic administration of moxonidine in hypertensive rats SHR-SP].
abstract: Study of the hemodynamic response (arterial pressure and heart rate) by radio- and telemetric techniques in stroke-prone hypertensive rats (SHR-SP) aged 6-7 months showed that a chronic oral administration of moxonidine at a daily dose of 2 and 10 mg/kg) leads to hypotension (7 +/- 3 and 21 +/- 5%, respectively) and bradycardia (5 +/- 1 and 14 +/- 5%, respectively). The moxonidine administration at a greater dose violated the circadian heart rate profile, reduced the motor activity of rats by 34 +/- 15%, and showed a drug dependence syndrome in the heart rate (but not in the arterial pressure). It is concluded that moxonidine administration at large doses may give rise to side effects.
authors: Pushchino Department, Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
authors: O N
authors: ON
authors: Khokhlova
authors: A N
authors: AN
authors: Murashev
authors: L N
authors: LN
authors: Lavrova
authors: O S
authors: OS
authors: Medvedev
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002940:Circadian Rhythm; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D007022:Hypotension / Q000139:chemically induced; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011918:Rats, Inbred SHR; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
chemical_list: D000959:Antihypertensive Agents; D007093:Imidazoles; C043482:moxonidine